Big cure and little cure are both pharmaceutical companies. big cure presently has a potential "blockbuster" drug before the food and drug administration (fda) waiting for approval. if approved, big cure's blockbuster drug will produce $1 billion in net income for big cure. little cure has ten separate, less important drugs before the fda waiting for approval. if approved, each of little cure's drugs would produce $50 million in net income. the probability of the fda approving a drug is 50%. what is the expected payoff for little cure's ten drugs?

On january 1, 2018, jay company acquired all the outstanding ownership shares of zee company. in assessing zee's acquisition-date fair values, jay concluded that the carrying value of zee's long-term debt (8-year remaining life) was less than its fair value by $21,600. at december 31, 2018, zee company's accounts show interest expense of $14,440 and long-term debt of $380,000. what amounts of interest expense and long-term debt should appear on the december 31, 2018, consolidated financial statements of jay and its subsidiary zee? long-term debt $401,600 $398,900 $401,600 $398,900 interest expense $17,140 $17,140 $11,740 $11,740 a. b. c. d.

T-comm makes a variety of products. it is organized in two divisions, north and south. the managers for each division are paid, in part, based on the financial performance of their divisions. the south division normally sells to outside customers but, on occasion, also sells to the north division. when it does, corporate policy states that the price must be cost plus 20 percent to ensure a "fair" return to the selling division. south received an order from north for 300 units. south's planned output for the year had been 1,200 units before north's order. south's capacity is 1,500 units per year. the costs for producing those 1,200 units follow

If the family’s net monthly income is 7,800 what percent of the income is spent on food clothing and housing?